Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse. A Prospective Multicenter Observational Study

NCT07092670 is registered in ClinicalTrials.gov with Intergruppo Melanoma Italiano as lead sponsor.

NCT NCT07092670
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07092670 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse. A Prospective Multicenter Observational Study
Lead sponsor
Intergruppo Melanoma Italiano
Phase
Observational
Overall status
Recruiting
Start date
August 4, 2025
Completion date
August 31, 2032
Enrollment
270 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

fertility, melanoma